Research Article
PPP1R12A Copy Number Is Associated with Clinical Outcomes of Stage III CRC Receiving Oxaliplatin-Based Chemotherapy
Figure 1
Kaplan-Meier survival curves of patients with stage III, IIIB, and IIIC disease receiving oxaliplatin-based chemotherapy. (a) RFS in total stage III; (b) RFS in stage IIIB; (c) RFS in stage IIIC. MRT: median recurrence time.
(a) |
(b) |
(c) |